# 足踝设备市场 > 足踝设备市场研究报告，按设备类型（骨科植入物和设备（固定设备（内部固定设备（螺钉、板、线和钉、融合钉、钉）、外部固定设备（单侧固定器、环形踝固定器、混合固定器））、关节植入物（踝植入物（踝关节置换设备）、距下关节植入物/距下关节重建设备、趾骨植入物））、软组织管理设备（人工肌腱和韧带、肌肉骨骼增强设备）、假肢（固态踝垫脚（SACH）假肢、单轴假肢、多轴假肢、动态响应/储能假肢、微处理器控制（Mpc）假肢）、支撑和支持设备），按应用（创伤、糖尿病、神经系统疾病、中足关节融合、畸形矫正、其他），按最终用户（医院和诊所、物理治疗中心、学术和研究机构）以及地区（北美、欧洲、亚太地区、南美、中东和非洲） - 预测至2035年 - **Forecast Period:** 2025 - 2035 - **CAGR:** 2.89% - **2024:** $ 4.51 Billion - **2025:** $ 4.64 Billion - **2035:** $ 6.17 Billion - **Key Players:** Companies such as Stryker Corporation (US), DePuy Synthes (US), Zimmer Biomet (US), Smith & Nephew (GB), Medtronic (US), Apex Foot Health Industries (US), Orthofix Medical Inc. (US), B. Braun Melsungen AG (DE), Conmed Corporation (US) are some of the major participants in the global market. **Report ID:** MRFR/HC/29428-CR · **Pages:** 255 · **Author:** Rahul Gotadki · **Last Updated:** June 02, 2026 **URL:** https://www.marketresearchfuture.com/reports/foot-ankle-device-market-31199 --- ## Market Summary ## **Global Foot and Ankle Device Market Overview** The Foot and Ankle Device Market was valued at USD 5.88 Billion in 2024. The Foot and Ankle Device Market industry is projected to grow from USD 6.25 Billion in 2025 to USD 12.68 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.32% during the forecast period (2025-2035). The increasing incidence of sports-related injuries, rising awareness and patient education and research and innovation are driving the growth of the Foot and Ankle Device Market. As per the Analyst at MRFR, the increasing incidence of sports-related injuries, rising awareness and patient education, and research and innovation are major factors driving the growth of the Foot and Ankle Device Market.  However, stringent regulatory requirements, reimbursement challenges, and voluntary product recalls by market players are expected to hamper market expansion. Nevertheless, the growing geriatric population and technological advancements in device design are anticipated to create lucrative opportunities for industry.  **FIGURE 1: FOOT AND ANKLE DEVICE MARKET VALUE (2019-2035) USD BILLION** ** Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review** ## **Foot and Ankle Device Market****Opportunity** ### **GROWING GERIATRIC POPULATION** The rapidly expanding geriatric population worldwide is creating highly lucrative growth opportunities for the Foot and Ankle Device Market, driven by the increasing prevalence of age-related orthopedic conditions such as osteoarthritis, rheumatoid arthritis, fractures, and degenerative bone disorders. As individuals age, the natural wear and tear on joints, reduced bone density, and slower healing processes contribute to a higher demand for advanced foot and ankle devices, including implants, braces, prosthetics, and surgical instruments.  Furthermore, the increasing geriatric population in North America, Europe, and Asia-Pacific will create lucrative growth opportunities in the upcoming years. Additionally, the rising preference for minimally invasive surgeries and innovative treatment options among elderly patients further accelerates market expansion. Governments and healthcare providers are increasingly focusing on improving mobility and quality of life for seniors, leading to greater investments in orthopedic care and rehabilitation solutions.  Consequently, medical device manufacturers are capitalizing on this demographic shift by developing specialized, durable, and patient-friendly foot and ankle devices, ensuring sustained market growth in the coming years. This trend not only enhances revenue prospects for industry players but also fosters advancements in personalized and long-term orthopedic care solutions tailored to the aging population. ## **Foot and Ankle Device Market****Segment Insights** ### **Foot and Ankle Device****by Device Type Insights** Based on device type, the Foot and Ankle Device Market has been segmented into orthopedic implants and devices, soft-tissue management devices, prostheses, and bracing and support devices. The orthopedic implants and devices segment held the largest market share in 2024, and the soft-tissue management devices segment is the fastest-growing segment during the forecast period (2025 -2035). Orthopedic Implants and Devices is bifurcated into Fixation Devices, and Joint Implants. Soft-Tissue Management Devices is bifurcated into Artificial Tendons & Ligaments, and Musculoskeletal Reinforcement Devices.  Prostheses are bifurcated into Solid Ankle Cushion Heel (SACH) Foot, Single-Axial Prostheses, Multiaxial Prostheses, Dynamic Response/Energy-Storing Prostheses, and Microprocessor-Controlled (Mpc) Prostheses. The Orthopedic Implants and Devices segment held the largest share of the Foot and Ankle Device Market in 2024, driven by the increasing incidence of sports injuries, osteoarthritis, and trauma-related fractures. This segment includes Fixation Devices, such as plates, screws, and pins used to stabilize broken bones, and Joint Implants, which are commonly used in ankle replacement surgeries to restore joint function. Technological advancements, minimally invasive surgical techniques, and the growing aging population are further supporting the demand for these devices, making it a key contributor to overall market growth. ### **Foot and Ankle Device****by Application Insights** Based on applications, the Foot and Ankle Device Market has been segmented into trauma, diabetes, neurological disorders, midfoot arthrodesis, deformity correction, and others. The trauma segment held the largest market in 2024, and the diabetes segment is the fastest growing segment during the forecast period.  The trauma segment accounted for the largest share of the Foot and Ankle Device Market in 2024, primarily due to the rising number of road accidents, falls, and sports-related injuries leading to fractures and dislocations. This segment involves the use of devices such as plates, screws, and fixation systems for the surgical treatment of traumatic injuries. The increasing demand for early mobility, advancements in surgical techniques, and a growing aging population vulnerable to falls are key factors driving the dominance of this segment. ### **Foot and Ankle Device****by End User Insights** Based on end user, the Foot and Ankle Device Market has been segmented into hospitals & clinics, physiotherapy centers, and academic & research organizations. The hospitals & clinics segment held the largest market in 2024, and the physiotherapy Centers segment is the fastest growing segment during the forecast period.  The hospitals & clinics segment held the largest share of the Foot and Ankle Device Market in 2024, owing to the high volume of surgical procedures, availability of advanced medical infrastructure, and presence of specialized orthopedic departments. These facilities are often the first point of care for trauma and chronic foot and ankle conditions, driving demand for diagnostic, surgical, and post-operative care devices. The segment's growth is further supported by increasing patient admissions, skilled healthcare professionals, and favorable reimbursement policies. **FIGURE 2: FOOT AND ANKLE DEVICE MARKET SHARE BY****END USER****2024 AND 2035 (USD BILLION)** Source: Secondary Research, Primary Research, MRFR Database and Analyst Review ### **Foot and Ankle Device****Regional Insights** Based on the region, the Foot and Ankle Device Market has been segmented into North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America accounted for the largest market share in 2024 and is anticipated to reach USD 5.69 billion by 2035. However, Asia-Pacific is projected to grow at the highest CAGR of 9.37% during the forecast period. Major demand factors driving the North America market are a high prevalence of orthopedic disorders, a growing aging population, and increasing cases of sports injuries and diabetes-related foot complications.  Additionally, the presence of leading medical device manufacturers, advanced healthcare infrastructure, and favorable reimbursement policies contribute to strong market demand. Rising adoption of minimally invasive procedures and continuous innovation in orthopedic technologies further support the region’s market dominance. **FIGURE 3: FOOT AND ANKLE DEVICE MARKET VALUE BY REGION 2024 AND 2035 (USD BILLION)** Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review Further, the countries considered in the scope of the Application Tracking System Market are the US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC Countries, South Africa, Rest of Middle East & Africa and others. ## **Global Foot and Ankle Device Key Market Players & Competitive Insights** Many global, regional, and local vendors characterize the Foot and Ankle Device Market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality products to survive and succeed in an intensely competitive market. The major competitors in the market are ORTHOFIX Medical Inc, Arthrex, Inc, INVIBIO Ltd, Stryker, SMITH+NEPHEW, Globus Medical, Inc, CONMED Corporation, Johnson & Johnson Services, Inc, Zimmer Biomet Holdings, Inc, ACUMED LLC are among others. The Foot and Ankle Device Market is a consolidated market due to increasing competition, acquisitions, mergers and other strategic market developments and decisions to improve operational effectiveness. ### **Key Companies in the****Foot and Ankle Device Market****include** - ORTHOFIX Medical Inc - [Arthrex Inc](https://www.arthrex.com/foot-ankle/orthobiologics-products) - INVIBIO Ltd - Stryker - SMITH+NEPHEW - Globus Medical Inc - CONMED Corporation - Johnson & Johnson Services, Inc - Zimmer Biomet Holdings, Inc - ACUMED LLC ## Foot Ankle Device Industry Developments - **Q2 2024: Enovis Announces FDA 510(k) Clearance for STAR Patient Specific Instrumentation (PSI) for Total Ankle Replacement** Enovis received FDA 510(k) clearance for its STAR Patient Specific Instrumentation (PSI), designed to improve accuracy and efficiency in total ankle replacement procedures. - **Q2 2024: Paragon 28 Announces Launch of Phantom® High Arch System for Foot and Ankle Reconstruction** Paragon 28 launched the Phantom® High Arch System, a new device intended for complex foot and ankle reconstruction, expanding its portfolio of surgical solutions. - **Q1 2024: Stryker launches Prophecy® Infinity Resect-Through Guides for Total Ankle Arthroplasty** Stryker introduced the Prophecy® Infinity Resect-Through Guides, a new technology to enhance precision in total ankle arthroplasty procedures. - **Q2 2024: Ossio Receives FDA Clearance for OSSIOfiber® Hammertoe Fixation System** Ossio received FDA clearance for its OSSIOfiber® Hammertoe Fixation System, a bio-integrative implant for hammertoe correction in foot and ankle surgeries. - **Q1 2024: Paragon 28 Announces FDA Clearance and Launch of SMART 28™ Screw System** Paragon 28 received FDA clearance and launched the SMART 28™ Screw System, designed for use in foot and ankle fixation procedures. - **Q2 2024: Enovis Completes Acquisition of Novastep to Expand Foot and Ankle Portfolio** Enovis completed the acquisition of Novastep, a company specializing in foot and ankle solutions, to broaden its product offerings in the sector. - **Q1 2024: Stryker Announces Opening of New Global Technology Development Center in India** Stryker opened a new Global Technology Development Center in India, which will focus on research and development for orthopedic devices, including foot and ankle products. - **Q2 2024: Paragon 28 Announces Launch of Gorilla® Medial Column Plating System** Paragon 28 launched the Gorilla® Medial Column Plating System, designed to address complex foot and ankle deformities. - **Q1 2024: Enovis Announces Launch of DynaNail Helix™ for Charcot Foot and Ankle Reconstruction** Enovis launched the DynaNail Helix™, a new device for Charcot foot and ankle reconstruction, expanding its advanced fixation solutions. - **Q2 2024: Ossio Announces $38.5 Million Series C Financing to Accelerate Commercialization of Bio-Integrative Implants** Ossio raised $38.5 million in Series C funding to support the commercialization of its bio-integrative implants for foot and ankle procedures. - **Q1 2024: Paragon 28 Appoints New Chief Commercial Officer** Paragon 28 appointed a new Chief Commercial Officer to drive commercial strategy and growth in the foot and ankle device market. - **Q2 2024: Enovis Announces Partnership with Movendo Technology to Advance Robotic Rehabilitation for Foot and Ankle Patients** Enovis entered a partnership with Movendo Technology to integrate robotic rehabilitation solutions into foot and ankle patient care. ## **Foot and Ankle Device Market****Segmentation** ### **Foot and Ankle Device by Device Type Outlook** - [Orthopedic Implants](../../../reports/orthopedic-implant-market-838) and Devices - Fixation Devices - Internal Fixation Devices - Screws - Plates - Wires & Pins - Fusion Nails - Staple  - External Fixation Devices - Unilateral Fixators  - Ring Ankle Fixators - Hybrid Fixators - Joint Implants - Ankle Implants (Ankle Replacement Devices) - Subtalar Joint Implants/Subtalar Joint Reconstruction Devices  - Phalangeal Implants - Soft-Tissue Management Devices - Artificial Tendons & Ligaments - Musculoskeletal Reinforcement Devices - Prostheses - Solid Ankle Cushion Heel (SACH) Foot        - Single-Axial Prostheses        - Multiaxial Prostheses        - Dynamic Response/Energy-Storing Prostheses         - Microprocessor-Controlled (Mpc) Prostheses      - Bracing and Support Devices ### **Foot and Ankle Device by Application Outlook** - Trauma - Diabetes - Neurological Disorders    - Midfoot Arthrodesis    - Deformity Correction    - Others ### **Foot and Ankle Device by End User Outlook** - Hospitals & Clinics - Physiotherapy Centers - Academic & Research Organizations  ### **Foot and Ankle Device****Regional Outlook** - North America - US - Canada - Europe - Germany - France - UK - Italy - Spain - Russia - Rest of Europe - Asia-Pacific - China - India - Japan - South Korea - Malaysia - Thailand - Indonesia - Rest of Asia-Pacific - South America - Brazil - Mexico - Argentina - Rest of South America - Middle East & Africa - GCC Countries - South Africa - Rest of Middle East and Africa ## Market Drivers ### Increase in Sports Participation 不同人群体育参与度的增加是市场的重要推动力。随着越来越多的人从事体育活动，运动相关损伤的发生率也在增加，特别是足部和踝部区域。这一趋势导致对脚踝支架和支撑鞋等防护装置的需求增加。最近的统计数据表明，运动损伤占足部和踝关节疾病的很大一部分，促使运动员和娱乐参与者寻求有效的解决方案。   制造商正在通过开发满足活跃个人需求的专业产品来满足这一需求。随着健身和运动文化的不断发展，足踝器械行业可能会从这一趋势中受益，因为专为伤害预防和康复而设计的产品范围不断扩大。   - PubMed 研究表明，在影响下肢的所有肌肉骨骼损伤中，近 25% 与运动相关的活动有关，其中很大一部分影响足部和脚踝区域。不断增加的伤害负担导致对支具、矫形器和防护装置的需求不断增加，特别是在需要增强稳定性和伤害预防支持的运动员和活跃人群中。 ### Growing Awareness of Preventive Care 医疗保健领域发生了向预防性护理的显着转变，这正在影响足部和脚踝设备行业。患者和医疗保健提供者越来越认识到早期干预对于预防足部和踝部疾病进展的重要性。这种意识正在推动对矫形器和支具等预防设备的需求，这些设备可以帮助减轻受伤和慢性病的风险。    市场数据表明，随着越来越多的人寻求积极的解决方案来保持足部健康，预防保健领域预计将显着增长。这种趋势可能会鼓励制造商开发创新产品，以满足注重健康的消费者的需求。因此，市场有望增长，因为它与更广泛的预防性医疗保健运动保持一致。   - 世界银行卫生指标显示预防性医疗支出稳步增长，许多国家将卫生总支出的 5% 以上用于预防性服务。这种转变正在推动矫形支撑和矫正装置的采用，因为早期干预可以降低长期残疾风险并改善足部和脚踝状况的活动能力。 ### Expansion of Healthcare Infrastructure 医疗保健基础设施的持续扩张是足部和脚踝设备行业的重要驱动力。随着医疗保健设施的改善和数量的增加，获得足部和脚踝疾病专业护理的机会变得越来越普遍。这种扩张在新兴市场尤其明显，这些市场对医疗保健的投资正在增加。医疗服务的普及可能会导致足部和脚踝疾病的诊断和治疗增加，从而增加对相关设备的需求。    此外，专业诊所和康复中心的建立正在促进更好的患者治疗效果，从而推动市场增长。随着医疗保健系统的不断发展，市场预计将经历重大进步，反映出对有效治疗方案的需求不断增长。   - 健康指标与评估研究所 (IHME) 报告称，过去 10 年全球康复服务的普及率提高了 30% 以上，特别是在新兴经济体。这一扩展支持提高足部和脚踝疾病的诊断率，并增加医院和康复中心对先进骨科设备的需求。 ### Technological Innovations in Device Design 技术进步在塑造足踝器械行业方面发挥着至关重要的作用。 3D 打印、智能材料和微创手术技术等创新正在彻底改变足部和脚踝设备的设计和功能。例如，通过 3D 打印引入定制矫形器显着改善了患者的治疗效果和满意度。    此外，将智能技术集成到设备中可以实时监控患者的进展情况，从而增强康复效果。在这些技术创新的推动下，预计未来几年市场的复合年增长率将达到 7% 左右。随着制造商不断投资于研发，市场预计将扩大，为患者提供更有效和个性化的解决方案。   - PubMed 索引的临床研究强调，与传统方法相比，3D 打印矫形装置可将患者贴合精度提高近 40%，从而提高舒适度和恢复效果。这项创新正在推动足部和脚踝治疗过程中更多地采用个性化植入物和微创矫形解决方案。 ### Rising Incidence of Foot and Ankle Disorders 足部和脚踝疾病的患病率日益增加是市场的主要驱动力。关节炎、糖尿病和运动相关损伤等疾病变得越来越常见，导致对专用设备的需求更高。根据最新数据，大约 20% 的成年人患有某种形式的足部或脚踝问题，需要医疗干预。   随着医疗保健提供者寻求有效的解决方案来管理这些疾病，不断增长的患者人数可能会推动市场向前发展。此外，人口老龄化特别容易患足部和踝部疾病，进一步增加了对创新设备的需求。因此，制造商正在专注于开发先进技术来应对这些挑战，从而促进市场的整体增长。   - IHME 全球负担研究表明，大约 20% 的成年人患有慢性肌肉骨骼足部或踝部疾病，由于人口老龄化和生活方式相关因素，患病率不断增加。这种不断上升的疾病负担极大地促进了全球对骨科植入物和支持设备的持续需求。 ## Future Outlook 足踝设备市场预计将在2024年至2035年间以2.89%的年均增长率增长，推动因素包括技术进步、足部疾病的日益普遍以及老年人口的增加。 **New opportunities:** - 开发具有集成健康监测功能的智能矫形设备。 到2035年，市场预计将实现显著增长，反映出不断变化的消费者需求和技术创新。 ## Segment Insights ### 按设备类型：骨科植入物和设备（最大）与软组织管理设备（增长最快） “足部和脚踝设备市场”展示了多种设备类型，包括占据市场主导地位的骨科植入物和设备。该细分市场的特点是其在外科手术中的关键作用，突显其相对于其他设备类型的 64% 的巨大市场份额。相比之下，软组织管理设备虽然目前市场份额较小，但由于对微创手术技术的日益重视以及对软组织损伤的认识不断增强，正在迅速获得关注。 施乐辉 (Smith & Nephew) 正在通过先进的植入系统和持续的产品创新来加强其骨科产品组合。该公司对创伤重建设备的关注满足了外科手术不断增长的需求，由于骨折固定和关节重建治疗的程序量很大，医院越来越多地采用该设备。 ### 按应用：创伤（最大）与糖尿病（增长最快） 足踝设备市场受到其应用领域的显着影响，其中创伤是最大的贡献者，占 58%。该细分市场占据了相当大的市场份额，反映出足部和脚踝受伤的高发率，尤其是在运动员和活跃人士中。相比之下，由于糖尿病患者数量的增加以及需要先进的足部护理解决方案的相关并发症，糖尿病领域正在快速增长。市场的增长主要是由于外伤和糖尿病等慢性病发病率的上升推动的。随着医疗保健提供者强调改善患者的治疗效果，对创新产品的需求激增。人口老龄化和久坐的生活方式等因素进一步促进了市场的扩大，凸显了创伤和糖尿病领域对有效治疗方案的需求。 Orthofix Medical Inc. 正在扩展以创伤为中心的解决方案，包括固定系统和四肢修复设备。紧急骨科手术的临床应用不断增加，推动了需求，而需要手术干预进行足部和脚踝重建的事故和运动损伤的发生率不断增加，这也推动了需求。 ### 按最终用户：医院和诊所（最大）与物理治疗中心（增长最快） 在足踝器械市场中，医院和诊所因其丰富的资源和大量的手术量而占据最大份额，达到71%。这些机构大力投资先进的足部和脚踝设备，以提高患者的治疗效果，从而占据重要的市场地位。相比之下，物理治疗中心正在迅速成为一个关键部分。他们对康复和整体患者护理的关注导致对专用设备的需求激增，使它们成为市场动态的显着贡献者。 B. Braun Melsungen AG 正在通过先进的手术器械和植入系统增强医院的骨科工作流程。三级护理医院的强大整合正在支持更高的手术效率和改善的患者治疗效果，从而巩固医院作为足部和脚踝设备生态系统中主要最终用户部分的地位。 ## Regional Market Share Analysis 根据地区，足踝设备市场已细分为北美、欧洲、亚太地区、南美、中东和非洲。北美在 2024 年占据最大的市场份额，预计到 2035 年将达到 56.9 亿美元。然而，亚太地区预计在预测期内将以 9.37% 的复合年增长率最高增长。推动北美市场的主要需求因素是骨科疾病的高患病率、人口老龄化以及运动损伤和糖尿病相关足部并发症病例的增加。  - CDC 数据报告称，美国有超过 5400 万成年人患有关节炎，这是导致足部和踝关节疾病需要骨科干预的主要原因。此外，Conmed Corporation 正在扩展其微创手术解决方案，支持医院和门诊手术中心更广泛地采用先进的足部和脚踝设备。 此外，领先的医疗器械制造商、先进的医疗基础设施和优惠的报销政策也促进了强劲的市场需求。微创手术的日益普及和骨科技术的持续创新进一步支撑了该地区的市场主导地位。 此外，应用程序跟踪系统市场范围内考虑的国家包括美国、加拿大、德国、英国、法国、俄罗斯、意大利、西班牙、欧洲其他地区、中国、印度、日本、韩国、马来西亚、泰国、印度尼西亚、亚太地区其他地区、巴西、墨西哥、阿根廷、南美洲其他地区、海湾合作委员会国家、南非、中东和非洲其他地区等。 - EMA 监管批准支持了欧洲各地先进骨科植入物的可用性的提高，每年进行超过 1,000 项医疗器械评估，有助于加快临床采用。这种监管效率正在加强足部和脚踝设备的市场渗透，改善患者在整个欧盟医疗保健系统中获得创新骨科治疗的机会。 ## Competitive Benchmarking 许多全球、区域和本地供应商是该市场的特色。市场竞争非常激烈，所有参与者都在争夺市场份额。激烈的竞争、技术的快速进步、政府政策的频繁变化以及环境法规是市场增长面临的关键因素。供应商根据成本、产品质量、可靠性和政府法规进行竞争。   供应商必须提供具有成本效益的高质量产品，才能在竞争激烈的市场中生存并取得成功。市场上的主要竞争对手包括 ORTHOFIX Medical Inc、Arthrex, Inc、INVIBIO Ltd、Stryker、SMITH+NEPHEW、Globus Medical, Inc、CONMED Corporation、Johnson & Johnson Services, Inc、Zimmer Biomet Holdings, Inc、ACUMED LLC 等。由于竞争加剧、收购、兼并和其他战略性市场发展以及提高运营效率的决策，该市场是一个整合的市场。 ## Recent News & Developments - **2024 年第二季度：Enovis 宣布 FDA 510(k) 批准用于全踝关节置换术的 STAR 患者专用器械 (PSI)**Enovis 的 STAR 患者专用器械 (PSI) 获得 FDA 510(k) 许可，该器械旨在提高全踝关节置换手术的准确性和效率。 - **2024 年第二季度：Paragon 28 宣布推出用于足部和脚踝重建的 Phantom® 高足弓系统**Paragon 28 推出了 Phantom® 高足弓系统，这是一种用于复杂足部和脚踝重建的新设备，扩大了其手术解决方案组合。 - **2024 年第一季度：Stryker 推出 Prophecy® Infinity 全踝关节置换术切除导板**Stryker 推出了 Prophecy® Infinity 切除导向器，这是一项提高全踝关节置换手术精度的新技术。 - **2024 年第二季度：Ossio 的 OSSIO Fiber® Hammertoe 固定系统获得 FDA 批准**Ossio 的 OSSIO Fiber® 获得 FDA 批准[锤状趾](https://www.marketresearchfuture.com/reports/hammertoe-market-4172)固定系统，一种生物集成植入物，用于足部和踝关节手术中的锤状趾矫正。 - **2024 年第一季度：Paragon 28 宣布 FDA 批准并推出 SMART 28™ 螺钉系统**Paragon 28 获得 FDA 批准并推出了 SMART 28™ 螺钉系统，专为足部和踝关节固定手术而设计。 - **2024 年第二季度：Enovis 完成对 Novastep 的收购，以扩大足部和脚踝产品组合**Enovis 完成了对 Novastep（一家专门从事足部和脚踝解决方案的公司）的收购，以扩大其在该领域的产品范围。 - **2024 年第一季度：Stryker 宣布在印度开设新的全球技术开发中心**史赛克在印度开设了一个新的全球技术开发中心，该中心将专注于骨科设备的研发，包括足部和脚踝产品。 - **2024 年第二季度：Paragon 28 宣布推出 Gorilla® 内侧柱电镀系统**Paragon 28 推出了 Gorilla® 内侧柱电镀系统，旨在解决复杂的足部和脚踝畸形问题。 - **2024 年第一季度：Enovis 宣布推出用于 Charcot 足和踝关节重建的 DynaNail Helix™**Enovis 推出了 DynaNail Helix™，这是一种用于 Charcot 足部和踝关节重建的新设备，扩展了其先进的固定解决方案。 - **2024 年第二季度：Ossio 宣布进行 3850 万美元的 C 系列融资，以加速生物集成植入物的商业化**Ossio 在 C 系列融资中筹集了 3850 万美元，以支持其用于足部和脚踝手术的生物集成植入物的商业化。 - **2024 年第一季度：Paragon 28 任命新首席商务官**Paragon 28 任命了一位新的首席商务官，以推动商业战略和市场增长。 - **2024 年第二季度：Enovis 宣布与 Movendo Technology 合作，推进足踝患者的机器人康复**Enovis 与 Movendo Technology 建立合作伙伴关系，将机器人康复解决方案集成到足部和脚踝患者护理中。 ## Report Scope | 2024年市场规模 | 45.1（十亿美元） | | --- | --- | | 2025年市场规模 | 46.4（十亿美元） | | 2035年市场规模 | 617.1（十亿美元） | | 复合年增长率（CAGR） | 2.89%（2024 - 2035） | | 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 | | 基准年 | 2024 | | 市场预测期 | 2025 - 2035 | | 历史数据 | 2019 - 2024 | | 市场预测单位 | 十亿美元 | | 主要公司简介 | 市场分析进行中 | | 覆盖的细分市场 | 市场细分分析进行中 | | 主要市场机会 | 先进材料和智能技术的整合提升了足踝设备市场的性能。 | | 主要市场动态 | 技术进步和监管变化推动了足踝设备市场的创新和竞争。 | | 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 | ## Frequently Asked Questions **Q: 足踝设备市场的当前估值是多少？** A: 截至2024年，足踝设备市场的价值为45.1亿美元。 **Q: 到2035年，足踝设备市场的预计市场估值是多少？** A: 预计到2035年，市场估值将达到6171亿美元。 **Q: 2025年至2035年，足踝设备市场的预期CAGR是多少？** A: 预计2025年至2035年期间，足踝设备市场的年均增长率（CAGR）为2.89%。 **Q: 足踝设备市场包括哪些细分市场？** A: 市场包括以下细分领域：骨科植入物和设备、软组织管理设备、假肢以及支撑和支持设备。 **Q: 2024年骨科植入物和设备的估值是多少？** A: 2024年，骨科植入物和设备的估值为15亿美元。 --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/foot-ankle-device-market-31199*